Importance of the conserved residues in the peptidoglycan glycosyltransferase module of the class A penicillin-binding protein 1b of Escherichia coli. by Terrak, Mohammed et al.
Importance of the Conserved Residues in the Peptidoglycan
Glycosyltransferase Module of the Class A Penicillin-binding
Protein 1b of Escherichia coli*□S
Received for publication,April 28, 2008, and in revised form, June 23, 2008 Published, JBC Papers in Press, August 13, 2008, DOI 10.1074/jbc.M803223200
Mohammed Terrak‡1, Eric Sauvage‡, Adeline Derouaux‡, Dominique Dehareng‡, Ahmed Bouhss§,
Eefjan Breukink¶, Sylvie Jeanjean‡, and Martine Nguyen-Diste`che‡
From the ‡Centre d’Inge´nierie des Prote´ines, Institut de Chimie, Universite´ de Lie`ge, B6a, B-4000 Sart-Tilman, Belgium, the
§Laboratoire des Enveloppes Bacte´riennes et Antibiotiques, Institut de Biochimie et BiophysiqueMole´culaire et Cellulaire, UMR
8619 CNRS, Universite´ Paris-Sud 11, 91405 Orsay, France, and the ¶Department of Biochemistry of Membranes, Bijvoet Center for
Biomolecular Research, Institute of Biomembranes, Utrecht University, Padualaan, 8, 3584 CH, Utrecht, The Netherlands
The peptidoglycan glycosyltransferase (GT) module of class A
penicillin-binding proteins (PBPs) andmonofunctional GTs cata-
lyze glycan chain elongation of the bacterial cell wall. These
enzymes belong to the GT51 family, are characterized by five con-
served motifs, and have some fold similarity with the phage 
lysozyme. In thiswork,wehavesystematicallymodifiedall thecon-
served amino acid residues of the GT module of Escherichia coli
class A PBP1b by site-directed mutagenesis and determined their
importance for the in vivo and in vitro activity and the thermosta-
bility of the protein. To get an insight into theGT active site of this
paradigm enzyme, amodel of PBP1b GT domain was constructed
based on the available crystal structures (PDB codes 2OLV and
2OLU). The data show that in addition to the essential glutamate
residuesGlu233ofmotif 1andGlu290ofmotif 3, the residuesPhe237
andHis240 ofmotif 1 andGly264,Thr267,Gln271, andLys274 ofmotif
2, all located in the catalytic cavity of the GT domain, are essential
for the in vitro enzymatic activity of the PBP1b and for its in vivo
functioning. Thus, the first three conservedmotifs containmost of
the residues that are required for theGTactivity of thePBP1b.The
residuesAsp234, Phe237,His240, Thr267, andGln271 are proposed to
maintain the structure of the active site and the positioning of the
catalytic Glu233.
Most bacteria are surrounded by cell wall peptidoglycan, a
net-like polymer consisting of glycan strands made of alternat-
ing -1,4-linked GlcNAc and N-acetylmuramic acid (Mur-
NAc)2 residues cross-linked by peptides (1, 2). Peptidoglycan
metabolism is linked to cell cycle and function to confer shape
and osmotic stability to the cell (3–5). Its assembly is complex
and requires the contribution of several proteins (polymerases,
hydrolases, and skeletal proteins), which are believed to form
protein assemblages specialized in cell elongation and division
(3, 6, 7).
Multimodular penicillin-binding proteins (PBPs) are mem-
brane-bound enzymes responsible for peptidoglycan polymer-
ization (8, 9). They are essentially two-module proteins that
belong either to classAor to class B, depending on the structure
and the catalytic activity of their N-terminal module. The
C-terminal penicillin-binding domain of both classes has a
transpeptidase activity, catalyzing peptide cross-linking
between two adjacent glycan chains. In class A, the N-terminal
module is responsible for their glycosyltransferase (GT) activ-
ity. Thismodule catalyzes the polymerization of uncross-linked
glycan chains from a membrane bound intermediate called
lipid II, the GlcNAc-MurNAc-(pentapeptide) linked to the
undecaprenyl via a pyrophosphate bridge (Fig. 1). In class B, the
N-terminalmodule appears to play a role in cellmorphogenesis
(10). Monofunctional enzymes similar to the GT module of
class A PBPs also exist in some bacteria, but their exact role is
still unknown (11).
Crystal structures of the Staphylococcus aureus class A PBP2
in apo form (PDB code 2OLU) and in complex with moenomy-
cin (PDB code 2OLV) and the GT module of Aquifex aeolicus
PBP1a (PDB code 2O9O) reveal that the GT module has some
similarity to phage  lysozyme and shed light on its active site
(12, 13). The available structural and biochemical data provide
better understanding of themechanism of glycan chain elonga-
tion by the glycosyltransferases (12–15). The essential gluta-
mate of motif 1 functions as active site general base and depro-
tonates theGlcNAc 4-OHgroup of lipid II acting as an acceptor
for nucleophilic attack on the reducing end of the growing gly-
can chain acting as a donor (16, 17) (Fig. 1). The reaction results
in the formation of a -1,4 glycosidic linkage with inversion of
the configuration at the anomeric C1 carbon of MurNAc. The
departure of the leaving diphospho-undecaprenyl group is
probably assisted by anionic interaction with the second con-
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Supplemental Material can be found at: 
served glutamate in motif 3 via a divalent metal cation. The
translocation of the new product from the acceptor to the
donor site may be driven by the high affinity of the pyrophos-
phate for the positively charged donor site (12). Apart from
S. aureus PBP2 (18), the activity of other GTs (16, 19, 20) was
dependent on metal ions, but the exact role of bivalent ions in
the reaction still need to be determined.
Themultimodular class A PBP1b (Fig. 2) is themajor bifunc-
tional peptidoglycan synthase in Escherichia coli endowed with
GT and transpeptidase activities (17, 21–23). It is an essential
constituent of the peptidoglycan synthesis machineries
involved in cell elongation and cell division (24–26), where its
function is probablymodulated by other proteins, such as FtsN,
which stimulates its activity (27).
E. coli PBP1b is themost studied class A PBP and exhibits the
highest peptidoglycan polymerase activity in vitro (16, 17, 24,
25, 28). However, no tridimensional structure is available for
this protein, and its active site is not well characterized. The
crystal structure of the PBP1b ortholog, S. aureus PBP2 (PDB
code 2OLU), is known (12), and the
two proteins share high sequence
similarity with each other. Based on
the PBP2 structure, we have con-
structed a model of PBP1b GT
domain to get an insight into its
active site. The GT domains of the
two PBPs, like almost all the pro-
teins of the GT51 family (29), are
characterized by five characteristic
motifs containing several invariant
amino acids, most of them located
in the catalytic cavity of these
enzymes (Figs. 2 and 3). We have
modified all the conserved residues
within these motifs and determined
their importance for the function of
the PBP1b both in vitro and in vivo.
EXPERIMENTAL PROCEDURES
Construction of the Mutants—
Single amino acid mutations were
introduced into the ponB gene
using the QuikChange site-directed
mutagenesis kit (Stratagene) as de-
scribed previously (17). Briefly, the
primers (supplemental Table S1)
were used to PCR-amplify the
pDML920C plasmid containing the
1300-bp NcoI-PstI sequence encod-
ing theHis tag (Met46–Gln423)PBP1b
GT module. After DNA sequencing
to check for the desiredmutation and
absence of any errors, the 840-bp
NheI-SacII or 300-bp SacII-PstI frag-
ments were exchanged with the cor-
responding unmodified segments of
the expression plasmid pDML924
carrying ponB gene encoding the His
tag PBP1b (Met46–Asn844) (17) and sequenced. Supplemental
Table S1 shows the pDML924 derivatives (E to N) allowing the
production of PBP1b mutants.
Expression and Purification of the His Tag PBP1b and the
Mutants—E. coli BL21 (DE3)/pDML924-E to R transformants
were grown at 37 °C in Luria Bertani (LB) medium containing
50 g of kanamycin/ml. When the absorbance at 600 nm
reached a value of 0.6, the cultures were supplemented with 1
mM IPTG and grown for two additional hours. The cells were
disrupted and fractionated. The membrane-bound PBPs were
solubilized in 25 mM Tris-HCl, pH 7.5, 1 M NaCl, and l %
CHAPS and purified on Ni2-Sepharose column (HisTrap HP
from GE healthcare) as described previously (17).
Complementation Assay—The in vivo activity of the PBP1b
mutants was assayed by their ability to complement for the
deletion of PBP1b and the thermosensitive PBP1a in E. coli
strain EJ801 at 42 °C (30). EJ801 was transformed with the plas-
mids pDML924-E to R at 30 °C. The transformants were first
grown at 30 °C in LB medium containing 30 g of kanamycin/
FIGURE 1. Mechanism of glycan chain elongation by peptidoglycan glycosyltransferases. The catalytic
base (glutamate of motif 1) catalyzes the deprotonation of the GlcNAc 4-OH of lipid II, and the activated
nucleophile then directly attacks the C1 of the lipid-linked MurNAc of the growing polysaccharide chain.
FIGURE 2.Organization of the multimodular PBP1b and structural model of its GTmodule. A, schematic
representation of [H6]PBP1b. PBP1b has a cytoplasmic N-terminal tail (1–63 in PBP1b; 46–63 in PBP1b)
followed by a transmembrane anchor (64–87), an insertion of about 100 amino acids (88–185), and the GT
(185–398) and transpeptidase (TP) (441–844)modules separated by a linker. B, sequence alignment (ClustalW)
of the GT module of class A PBPs and monofunctional GTs. Eco, E. coli; Sau, S. aureus; Aae, A. aeolicus. The
secondary structures of S. aureus PBP2 are shown on top of the sequences, andmotifs 1–5 are underlinedwith
the conserved residues in bold type.Numbers indicate the position of the first and last residues. The C-terminal
end of monofunctional GT (MGT) is indicated by *.
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ml. The preculture was then diluted in 20 ml of fresh LB
medium in the absence and the presence of IPTG to an A600 nm
value of 0.1–0.3, and the absorbance of the culture was moni-
tored for 4 h at 42 °C.
Glycosyltransferase Assay—The [14C]meso-diaminopimelic
acid (A2pm)-labeledC55 lipid II intermediate (N-acetylglucosami-
nyl-N-acetylmuramoyl(L-Ala--D-Glu-(L)-meso-A2pm-(L)-D-Ala-
D-Ala)-pyrophosphate-undecaprenol) was prepared essentially as
described previously (31).
In vitro peptidoglycan polymerization was performed by
incubation of the [14C]lipid II (0.5–5 M; 0.126 Ci/nmol) and
the His tag PBP1b or the mutants (20 nM to 1 M) in 50 mM
Tris-HCl, pH 7.5; 0.046% CHAPS; 33 mM NaCl; 10 mM MgCl2;
0.5% decyl polyethylene glycol; 12.5% 1-octanol; 25% dimethyl
sulfoxide (DMSO) for 15–60 min at 30 °C. The reaction prod-
ucts were separated by an overnight chromatography onWhat-
man No. 1 filter paper in isobutyric acid:1 M ammonium
hydroxide (5:3; V/V) and analyzed as described previously (17).
Interaction of the PBP1b Mutants with Fluorescent Ampicil-
lin or [14C]Benzylpenicillin—[14C]Benzylpenicillin (54 nCi
nmol1) was from Amersham Biosciences. Fluoresceyl-labeled
ampicillinwas prepared as described previously (32). The inter-
action between PBP1b and -lactams was analyzed using the
same procedure as described previously (17, 19).
Thermostability of the PBP1b Mutants—Purified PBP1b and
PBP1b mutants (5 M final concentration) were incubated at
60 °C for various times and then labeled with fluoresceyl-ampi-
cillin (104 M final concentration) in 25 mM Tris-HCl, pH 7.5,
0.5 M NaCl, and 0.7% CHAPS (buffer A) for 5 min at 30 °C. The
samples were analyzed by SDS-PAGE, and the acyl-enzyme
complex formedwas detectedwith aMolecular Imager scanner
and analyzed with the Quantity One software (Bio-Rad).
PBP1b GT Domain Modeling—Amodel of E. coli PBP1b GT
domain was constructed based on S. aureus PBP2 crystallo-
graphic structure (Protein Data Bank code 2OLV) (12). From
residue 185 to residue 400 (PBP1b numbering), S. aureus PBP2
side chains have been replaced by the equivalent ones of E. coli
PBP1b and have been reoriented so as to avoid steric clashes.
Side chains positions havenot beenmodifiedwhen the side chains
are common to both enzymes. Residues 255–263 have not been
modeled as the structure of equivalent residues in S. aureus PBP2
is unknown, like residues 320–323,which are not present inS. au-
reus PBP2. The model was energy-minimized with the program
Insight II (BIOSYMTechnologies, SanDiego,CA;Accelrys Soft-
ware Inc.) in a two-step process, on a all-atom framework, thus
taking all the hydrogen atoms into account. In the first step, all the
C atoms were fixed, and the rest of the protein was subject to a
geometry optimization. In the second step, the geometry optimi-
zation was performed without restraint.
RESULTS
Model of the GT Domain of E. coli PBP1b—Alignment of the
E. coli PBP1b GT module sequence, starting from residues
212–398, with that of S. aureus PBP2 showed 39% of identity
and 65%of similarity. This high degree of conservation suggests
that their three-dimensional structures must also be well con-
served. Amodel of E. coli PBP1b GT domain based on the crys-
tal structure of S. aureus PBP2 (PDB code 2OLV) (12) was con-
structed (see “Experimental Procedures”). The fold adopted by
the 212–398 polypeptide model with the five conserved motifs
is shown in Fig. 3A.
At least 18 amino acid residues within thesemotifs are highly
or strictly conserved (Fig. 2B). In the E. coli PBP1b GT domain,
four of them (Glu233, Asp234, Glu290, and Tyr310) were analyzed
previously (17). The 14 additional conserved residues in the
PBP1b were modified by site-directed mutagenesis, and the
mutants were characterized (Table 1).
Expression, Purification, and Properties of the PBP1b
Mutants—All the PBP1b mutants were expressed and purified
in the same conditions as for the wild type, except that
PBP1bT267A could only be expressed at 18 °C instead of 37 °C,
and the PBP1b R286A was not produced even at 18 °C (Fig. 4).
The PBP1b mutants were characterized in terms of penicillin
binding activity, thermostability, in vivo activity by comple-
mentation, and GT activity using lipid II as substrate. The
expression levels (2–3 mg of protein/liter of culture) and the
stability of themutants, unless otherwisementioned, were sim-
ilar to those of the wild-type protein. The penicillin binding
capacity of the native PBP1b was reduced by 50% after 8–10
min of preincubation at 60 °C. The acylation rate constants of
the PBP1b mutants by -lactams were comparable with those
of the native PBP1b (500–700M1 s1 for [14C]benzylpenicillin
or 20–30 M1 s1 for fluoresceyl-ampicillin). The results of the
complementation experiments with and without induction
were similar unless otherwise indicated.
Mutations inMotif 1 (233EDRHFYEHDG242), F237A, H240Q,
or H240A andG242A—Motif 1 is located in a loop between the
helices 1 and 2 and contains five conserved residues, Glu233,
Asp234, Phe237,His240, andGly242 (Figs. 2 and 3A). The residues,
Phe237, His240, and Gly242 were modified to Ala. In addition,
His240 was modified to Gln. The thermostability and the peni-
cillin binding activity of the four PBP1bmutants were similar to
those of the wild type. The PBP1b F237A and H240A were
inactive in vivo as assayed by complementation using the ponA
(ts) ponB EJ801 E. coli strain producing a thermosensitive
PBP1a and depleted of PBP1b (see “Experimental Procedures”),
whereas PBP1b H240Q was partially functional (Fig. 5), and
G242A was only active in the presence of IPTG (data not
shown). TheGT activity of PBP1b F237A andH240Awas com-
pletely abolished. The glycan polymerase activities of PBP1b
H240Q and G242A were 8- and 22-fold lower than that of the
wild type with efficiencies of 4700 M1 s1 and 1800 M1 s1,
respectively, when compared with 39,000 M1 s1 for the wild
type (Table 1).
Mutations in Motif 2 (264GASTLTQQLVK274), G264L,
S266A, T267A, Q271A, and K274A—We propose that motif 2
extends to Lys274 since the nature (Lys/Arg) of the residue at
this position is highly conserved among the hundreds of class A
PBPs/monofunctional GTs (CAZy (carbohydrate-active
enzymes) data base), and the three-dimensional structures of
the GT domain show that it may play an important role in the
binding of the substrate (12, 13). Motif 2 contains five con-
served residues starting before the 3 helix (Gly264, Ser266, and
Thr267) and extends through the whole helix (Gln271 and
Lys274) (Figs. 2B and 3A). To test their importance in the func-
tion of PBP1b, the mutations G264L, S266A, T267A, Q271A,
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and K274A were performed. The PBP1b G264L, S266A,
Q271A, and K274A mutants were expressed in stable form at
37 °C and behave as the wild-type protein. They all bound pen-
icillin, but their GT activity was completely abolished except
that of PBP1b S266A, which had a 6-fold reduced GT activity
with an efficiency of 6300 M1 s1 (Table 1) and was active in
FIGURE 3. Structuralmodel of PBP1bGTmodule (212–398) and close view into the catalytic site depicting thepositions of the studied conserved
residues in sticks. A, motif 1 (M1) is shown in yellow, motif 2 (M2) is shown in salmon, motif 3 (M3) is shown in cyan, motif 4 (M4) is shown in green, and
motif 5 (M5) is shown inmagenta. The catalytic Glu233 and the Glu290 residues are shown in sticks. B, Phe237 is part of a hydrophobic cluster. C, interaction
between Asp234 and His240 of motif 1 and Thr267 of motif 2. D, Gln271 and Tyr310 are within interacting distance of the catalytic Glu233. E, positively
charged residues within the donor site close to the Glu290 are shown. The figures were generated with the help of the PyMOL software.
TABLE 1
Properties of E. coli PBP1bmutants
The kinetic parameters were determined, with lipid II as substrate. In vivo activities of the mutants were determined by complementation assay at 42 °C with and without IPTG
induction in ponA (ts) ponB E. coli EJ801 doublemutant. The kinetic parameters values are themean of three to five separate experiments. indicates that themutant is active or
stable;, the mutant is not active or instable;, the mutant has intermediate activity or not less stable. ND, not determined because of low activity or instability of the protein.
In vitro activity Penicillin binding/thermostability kcat Km kcat/Km GT activity
s1 M M1 s1 %
PBP1b wild-typea  / 70 13 1.8 0.8 39,000 100%
I. E233Qa  / ND ND ND 0.2
D234Na,b  / 9.4 1.8 1.68 0.65 5600 14
F237A  /    0
H240A  /    0
H240Q  / 5.2 1.24 1.8 0.21 4700 7
G242A c / 2.9 1 1.6 0.9 1800 4
II. G264L  /    0
S266A  / 7.6 2 1.2 0.67 6300 11
T267Ab  /    0
Q271A  /    0
K274A  /    0
III. R286Ad  /    
K287A  / 44 10 1.2 0.6 36,500 63
E290Qa  / 1.44 0.4 0.4 0.2 3600 2
IV. K303Ab  / ND ND ND 
Y310Fa,d  /    
N312A  / 11 3.6 1.2 0.94 9200 15
V. R372A  / 13.4 4 1.1 0.63 12,200 19
L377Gb  / ND ND ND 
a From Ref. 17.
b These PBP1b mutants were expressed only at lower temperature or at lower level at 37 °C when compared with the wild-type.
c Active only after induction with IPTG.
d These mutants were not expressed at all ().
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the complementation assay (Fig. 5). PBP1bG264L, Q271A, and
K274A do not support the growth of E. coli EJ801 ponA (ts)
ponB at the nonpermissive temperature (Fig. 5). The PBP1b
T267Awas not expressed at 37 °C, but when the expressionwas
tested at 18 °C for 16 h, the protein was produced (Fig. 4). The
purified PBP1b T267A was stable and bound penicillin (Fig. 4)
but was devoid of GT activity and was inactive in the comple-
mentation assay at 42 °C (Fig. 5). The ability of the PBP1b
T267A to bind penicillin after incubation at 60 °Cwas similar to
the wild type (50% labeling after 8–10min at 60 °C), suggesting
that the mutation had not affected the overall stability and the
structure of the protein (other than the GT active site) but per-
haps affected the folding process of the protein, which was
restored at lower temperature.
Mutations in Motif 3 (286RKANE290), R286A and K287A—
Motif 3 is located at the beginning of the 4 helix and contains
three conserved residues, Arg286, Lys287, and Glu290 (Figs. 2B
and 3A). Arg286 and Lys287 were modified to Ala. The PBP1b
R286Amutant was not detected in induced cells using the same
condition as for the wild type. Its expression was also tested at
18 °C for 3–16 h, but no protein was produced (Fig. 4). This
mutation may have affected the expression or the folding and
stability of the protein. Moreover, when the plasmid encoding
the PBP1b R286A was used in the complementation assay, the
ponA (ts) ponB EJ801 strain was not able to grow at 42 °C. By
contrast, the behavior of the PBP1b K287A was similar to the
nonmutated protein with respect to the level of production,
thermostability, susceptibility to penicillin, glycan chain elon-
gation from lipid II (kcat/Km 36,500 M1 s1) (Table 1), and
in vivo activity.
Mutations in Motif 4 (303KDRILELYMN312), K303A and
N312A—Motif 4 holds within the entire 5 helix and contains
four conserved residues, Lys303, Ile306, Tyr310, and Asn312 (Figs.
2B and 3A). Lys303 andAsn312 weremodified toAla. The PBP1b
K303A mutant was produced at a 3-fold lower level than the
wild type. The K303A mutant from membrane preparations
bound penicillin, but the CHAPS-solubilized protein under-
went spontaneous precipitation during purification, making its
in vitro characterization difficult. This mutation may have
affected the stability of the protein. The plasmid, which
encoded the PBP1b K303A mutant, was not able to rescue the
strain EJ801 from lysis at the nonpermissive temperature,
showing that the protein was not functional in vivo. The PBP1b
N312A behaves as the wild type in terms of expression level,
stability, and penicillin binding. This mutant has 4-fold lower
GT activity than the wild type with an efficiency of 9200
M1 s1 (Table 1). E. coli EJ801 transformants expressing the
PBP1b N312A grew at 42 °C, indicating that the mutant was
active in vivo.
Mutations in Motif 5 (372RRNLVL377), R372A and L377G—
Motif 5 is located in themiddle of the8 helix and contains two
conserved residues, Arg372 and Leu377, which were modified to
Ala and Gly, respectively (Figs. 2 and 3A). The thermostability
of PBP1b R372A and its affinity for penicillin were similar to
those of thewild type. Themutant R372Awas active in vivo and
catalyzed glycan chain polymerization in vitro with an effi-
ciency of 12,200 M1 s1 (Table 1). The expression level (0.3
mg/l) and thermostability (50% labeling after 4 min at 60 °C) of
the PBP1b L377G were lower than those of the wild-type
PBP1b. The PBP1b L377G mutant was active in vivo in the
complementation assay and hadGTactivity in vitrowith lipid II
as substrate (kinetic parameters not determined). The PBP1b
mutants, which retained some activity (Table 1), all have their
kcat values affected to different extents, but there was almost no
change in the Km values.
DISCUSSION
PBP1b is themajor peptidoglycan polymerase in E. coli. It is a
bifunctional enzyme catalyzing both glycan chain elongation
and peptide cross-linking. Here we have studied the structure-
function relationship and the effect of point mutations within
the PBP1b GT domain on the peptidoglycan polymerase activ-
ity of the PBP1b.
The glycosyltransferase domain of the PBP1b catalyzes the
transfer of the lipid linked growing glycan chain, which acts
as the glycosyl donor, to the lipid II precursor, which func-
tions as the glycosyl acceptor (12, 14) (Fig. 1). The catalytic
baseGlu233 catalyzes the deprotonation of theGlcNAc 4-OHof
lipid II, and the activated nucleophile then directly attacks the
C1 of the lipid-linked MurNAc of the growing polysaccharide
chain (SN2-like mechanism). In addition to the essential dicar-
FIGURE 4. Expression and fluoresceyl-ampicillin labeling of some PBP1b
mutants. A and B, Coomassie Blue staining (A) and fluoresceyl-ampicillin (50
M) labeling (B) of PBPs after SDS-PAGE loaded with equivalent amount of
membrane extract from cells expressing PBP1b mutants at 37 °C. Lane 1,
F237A; lane 2, T267A; lane 3, Q271A; lane 4, R286A;Mmolecularmass stand-
ard. C, fluorescence detection of fluoresceyl-ampicillin labeled PBPs at 30 °C.
In lanes 5 and 6, the expression of the PBP1b R286A was realized at 18 and
37 °C, respectively. In lanes 7 and 8, the expression of PBP1b T267A was real-
ized at 18 and 37 °C, respectively (no overexpression of R286A was visible
after Coomassie Blue staining, not shown).
FIGURE 5. In vivo activity of PBP1bmutantsmodified inmotifs 1 and 2by
complementation assays at 42 °C using the ponA(TS) ponB E. coli strain
EJ801.WT, wild type.
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boxylic acid residue, theGTmodule contains several other con-
served residues, most of them clustered in the five conserved
motifs. The importance of these residues for the function of the
PBP1b was analyzed both in vitro and in vivo, and their possible
role is discussed below. The results presented here show a nice
correlation between the GT activity in vitro and the in vivo
activity of the mutants.
A three-dimensional structural model of E. coli PBP1b GT
domain was constructed using the x-ray structure of S. aureus
PBP2 (12). By similarity, the motif 1 containing the essential
Glu233 is located in a loop at the end of the 1 helix and just
before the flexible region, which encompasses the 2 helix (Fig.
3A). Therefore, the structure of the loop, which also contains
Asp234, Phe237, and His240, must be very important for the cor-
rect positioning of the glutamate and the activity of the enzyme.
The side chain of Phe237 is part of a hydrophobic cluster that
contains Tyr238 ofmotif 1, Leu272 ofmotif 2, Ile306 and Leu307 of
motif 4, and Leu229 on the 1 helix (Fig. 3B). This hydrophobic
cluster is likely to play an important role in the maintenance of
the structure of the motif 1 loop. In addition, the side chains of
Asp234 and His240 of motif 1 and Thr267 of motif 2 interact with
each other (Fig. 3C), and therefore, themutation of one of these
residues may destabilize the loop that holds Glu233, resulting in
the loss of activity. Consistently, the PBP1b mutants D234N,
F237A, H240A, and T267A were all not functional in vivo, and
only PBP1bD234Nhad 13%of thewild-typeGTactivity in vitro
(17). Note that although the PBP1b H240A was completely
inactive, the mutant H240Q, the activity of which was reduced
about 8-fold, was partially functional in the complementation
assay. These results show that the glutamine can replace the
histidine and suggest that the hydrogen bonds network of the
triadHis-Asp-Thr (Fig. 3C) is partiallymaintained in the PBP1b
H240Q mutant and is thus important for the activity.
According to themodel, theGlu233 side chain (motif 1) inter-
acts directly with that of Gln271 (motif 2) and the hydroxyl
group of Tyr310 (motif 4) (Fig. 3D). The PBP1b Q271A mutant
was completely inactive in vitro and in vivo, suggesting that this
substitution also had an effect on the position of the glutamate.
In the case of Y310F, themodified protein could not be isolated,
probably because Tyr310 may also play a role in the folding
process and stability of the protein (17).
Gly242 and Gly264 are located in the flexible region upstream
and downstream of the 2 helix. PBP1b G242Amutant has low
activity, and PBP1bG264Lmutantwas inactive, suggesting that
the flexibility of the region may be important for the activity of
the enzyme and that the mutations may have caused local con-
formational change or steric effect.
Residues Lys274 (motif 2), Arg286, and Lys287 (motif 3),
together with Arg282 (residues equivalent to Lys155, Arg167,
Lys168, and Lys163 in S. aureus), create a positively charged
pocket in the donor site (Fig. 3E) and may play a role in the
positioning of the negatively charged pyrophosphate of the
donor substrate (12). Below this region lays a hydrophobic sur-
face, which likely interacts with the membrane and where the
lipid moiety would bind. Among the positively charged resi-
dues, Lys274 seems to play a major role in the interaction with
the substrate as the modification of this residue into Ala com-
pletely abolished the in vivo and in vitro functions of the pro-
tein. The PBP1bR286Amutantwas not expressed, and its exact
role cannot be determined. However, the equivalent residue in
A. aeolicus (Arg136) was shown to be important for enzymatic
activity (15), and therefore, Arg286 may also play similar func-
tion in PBP1b. Lys287 seems not to be important since the
K287A mutant retained high GT activity and was functional
in vivo.
The PBP1b R372A retained 20% of GT activity in vitro and
was active in vivo. The equivalent residue to Arg372 in S. aureus
PBP2 (Arg249) was proposed to stabilize the deprotonated form
of the catalytic glutamate (12). A mutant of the equivalent res-
idue (R218A) inA. aeolicus PBP1a seems to bemore affected as
it retained only 10% of GT activity. Its in vivo activity is not
known. However, under certain conditions (more enzyme),
good turnover by A. aeolicus PBP1a was observed (15). One
explanation is that the role of Arg372 in the PBP1b mutant or
Arg218 in the PBP1a mutant may be taken over by the amino
group of a lysine downstream of helix 7, which is not strictly
conserved but is well positioned and could fold into the active
site upon substrate binding: Lys355 in E. coli PBP1b R372A
mutant and Lys200 in A. aeolicus PBP1a R218A mutant.
In contrast to E. coli PBP1b mutants F237A, H240A, and
T267A,whichwere completely inactive in vivo and in vitro even
when high protein concentrations (20–50 times more than the
wild type) were used in vitro to monitor their activity, the
mutants of the equivalent residues (F87A,H90A, andT117A) in
A. aeolicus PBP1a GT domain retain residual GT activity in
vitro (5–10%) (13, 15). These results suggest that some local
variation may exist between different GT domains. However,
the general tendency of the effects ofmutations inE. coliPBP1b
and A. aeolicus PBP1a is similar and shows that most of the
conserved residues of motifs 1, 2, and 3 play an important role
in the activity of their GT domains.
Consistent with the location of the first three conserved
motifs in the catalytic cavity of the GT domain, most of the
mutations in motifs 1 and 2 and to a lesser extent motif 3
severely affected the function of the PBP1b; only 2 of 12
mutants (S266A in motif 2 and K287A in motif 3) were fully
active in vivo, and these residues are probably dispensable.
Except from D234N (motif 1), T267A (motif 2), and R286A
(motif 3), whose thermostabilities were affected to different
extentswhen comparedwith thewild type, all themutantswere
thermostable. On the contrary, in terms of in vitro GT activ-
ity, six mutants (F237A, H240A, G264L, T267A, Q271A, and
K274A) were completely inactive, and D234N, G242A, and
Glu290 have only residual GT activities estimated at 13, 4.6,
and 2% of the wild-type activity, respectively.
In conclusion, motifs 1, 2, and 3 are important for the GT
activity of the PBP1b. The residues Asp234, Phe237, His240,
Thr267, and Gln271 are proposed to maintain the structure of
the active site and the positioning of the catalytic Glu233 and
may interact with the sugar moiety of the substrates as sug-
gested (12). Residue Lys274, located in a positively charged
pocket of the donor site, is involved in the positioning of the
pyrophosphate of the growing glycan chain. Motifs 4 and 5
seem less critical for the activity and may be involved mainly in
maintaining the overall structure of the GT domain.
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